| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |